Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Knowing when to update your personal budget is crucial for staying aligned with your financial goals. Explore the signs that indicate it's time for a revision.
19,364 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
MISMO and ALTA unveiled two datasets in candidate recommendation status to digitize ALTA title and settlement data, s...
CoStar expands its copyright lawsuit against Zillow, alleging more than 53,000 watermarked photos are used across lis...
A Layer-3 token listed on South Korea's Upbit surged in minutes, triggering a rapid rally described by traders as a v...
The kelpdao hack fallout pushes DeFi developers to accelerate migrations to Chainlink CCIP, with Solv Protocol leadin...
SVB Capital, a 110-person venture arm once tied to SVB Bank, is in limbo after regulators seized the parent bank. A p...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
MapleStory Universe, the blockchain-backed extension of Nexon's MapleStory, celebrates its first anniversary with 150...
NVIDIA and Alphabet reveal divergent AI strategies, highlighting hardware rails versus cloud-powered services, and si...
Meta Platforms delivered a powerful Q1 2026, with revenue surging and AI investment plans outlined, prompting investo...
Bitcoin jumped toward $77,000 after early reports of a breakthrough in Iran peace talks sparked risk-on trading. Anal...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...